Free Trial

Repligen (RGEN) Earnings Date, Estimates & Call Transcripts

Repligen logo
$145.65 +1.19 (+0.82%)
(As of 12/23/2024 05:26 PM ET)

Repligen Latest Earnings Summary

Actual EPS
(Nov. 12)
$0.43 Beat By $0.09
Consensus EPS
(Nov. 12)
$0.34

Repligen released Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.43, which beat the consensus estimate of $0.34 by $0.09. Quarterly revenue rose 9.7% year-over-year to $154.87 million, above analysts' expectations of $153.34 million. With a trailing EPS of -$0.37, Repligen's earnings are expected to grow 11.04% next year, from $1.54 to $1.71 per share.

Get Repligen Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Repligen and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$0.29$0.75$0.41 
Q2 20244$0.29$0.83$0.45 
Q3 20244$0.33$0.85$0.47 
Q4 20244$0.39$0.91$0.57 
FY 202416$1.30$3.34$1.89 
Q1 20253$0.38$0.44$0.40 
Q2 20253$0.46$0.47$0.47 
Q3 20253$0.42$0.46$0.44 
Q4 20253$0.50$0.59$0.54 
FY 202512$1.76$1.96$1.85 
Q1 20261$0.65$0.65$0.65 

Repligen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024Q3 2024$0.34$0.43+$0.09$0.87$153.34M$154.87M
7/30/2024Q2 2024$0.33$0.33-$0.60$154.11M$154.07M
5/1/2024Q1 2024$0.29$0.28 -$0.01$0.52$150.06M$151.31M
2/21/2024Q4 2023$0.33$0.33-$1.12$155.38M$155.74M
10/31/2023Q3 2023$0.14$0.23+$0.09$0.14$140.68M$141.20M
8/2/2023Q2 2023$0.49$0.53+$0.04$0.71$165.93M$159.20M
Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.
5/2/2023Q1 2023$0.59$0.64+$0.05$0.77$181.43M$182.70M
2/22/2023Q4 2022$0.58$0.68+$0.10$0.51$184.41M$186.80M

Repligen Earnings - Frequently Asked Questions

Repligen (NASDAQ:RGEN) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on RGEN's earnings history.

Repligen updated its FY 2024 earnings guidance on Tuesday, November, 12th. The company provided EPS guidance of 1.500-1.580 for the period, compared to the consensus EPS estimate of 1.430. The company issued revenue guidance of $630.0 million-$639.0 million.

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.34 by $0.09. Learn more on analysts' earnings estimate vs. RGEN's actual earnings.

The conference call for Repligen's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Repligen's latest earnings report can be read online.
Read Transcript

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $639.92 million.

Repligen (NASDAQ:RGEN) has a recorded net income of $35.60 million. RGEN has generated -$0.37 earnings per share over the last four quarters.

Repligen (NASDAQ:RGEN) has a forward price-to-earnings ratio of 94.58. The price/earnings-to-growth ratio is 4.64.

Repligen's earnings are expected to grow from $1.54 per share to $1.71 per share in the next year, which is a 11.04% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:RGEN) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners